# Brenntag account plan

> Brenntag distributes chemicals and ingredients from around 600 sites in more than 70 countries, with EUR 15,171.5m of sales in 2025.

## At a glance

Brenntag SE (Essen, Germany) connects chemical producers with chemical users: it buys around 20,000 chemicals and ingredients in bulk, stores, repacks, mixes and delivers them, and adds technical, regulatory and digital services. It operates around 600 sites in more than 70 countries and had 17,339 employees at year-end 2025 (16,942 at 30 June 2026). FY2025 sales were EUR 15,171.5m (-3.7% fx-adjusted), operating EBITDA EUR 1,287.5m and profit after tax EUR 269.7m. North America is its largest segment, and the U.S. alone accounts for EUR 5,165.4m of sales; 90.5% of employees work outside Germany.

## Business units

- **Brenntag Essentials** (EUR 10,370.3m FY2025 external sales (about 68.4% of Group)): Process chemicals for a wide range of industries, managed through geographic segments: EMEA, North America, Latin America, APAC and Transregional. FY2025 operating EBITA fell to EUR 658.7m, mainly on falling sales prices; in H1 2026 operating EBITDA rose to EUR 574m (+18.1% fx-adjusted).
- **Brenntag Specialties** (EUR 4,801.2m FY2025 external sales (about 31.6% of Group)): Ingredients and value-added services managed by industry: Life Science (Nutrition, Pharma, Beauty & Care) and Material Science (CASE, Construction, Polymers, Rubber). FY2025 operating EBITA fell to EUR 387.0m on lower volumes; in H1 2026 Material Science gross profit rose 11.9% while Life Science fell 3.4%.
- **North America (Essentials)** (EUR 4,694.1m FY2025 external sales (about 30.9% of Group)): The largest segment. FY2025 operating gross profit fell to EUR 1,443.6m on lower prices and volumes; Brenntag bought oilfield chemicals provider Chem Tech Services (Texas) in November 2025.
- **EMEA (Essentials)** (EUR 3,607.6m FY2025 external sales (about 23.8% of Group)): Acquisitions kept volumes roughly flat in 2025 while operating EBITA fell to EUR 225.1m. The Airedale Group acquisition (UK) adds blending, formulation and dilution capabilities.
- **Latin America (Essentials)** (EUR 968.4m FY2025 external sales (about 6.4% of Group)): The only growing segment in 2025, thanks to acquisitions, but carried a goodwill and intangible impairment of EUR 82.6m. H1 2026 operating EBITDA reached EUR 48m (+94.8%).
- **APAC (Essentials)** (EUR 823.8m FY2025 external sales (about 5.4% of Group)): Volumes fell after the sale of Raj Petro Specialties (India); impairments were booked citing US-China geopolitical uncertainty. Chinese producers are back in the region, pushing volumes aggressively.
- **Transregional (Essentials)** (EUR 276.4m FY2025 external sales (about 1.8% of Group)): BRENNTAG International Chemicals GmbH (BIC), which buys and sells chemicals in bulk internationally without regional boundaries.

## Strategic priorities

- **Sales and market share**: CEO Jens Birgersson's first priority is sales: empowering local sales teams, cross-selling between divisions, pairing pharma domain experts with Essentials salespeople, and winning back dormant customers (1,000 in the U.S. this year).
- **Clarity and simplification**: Since 1 December 2025 a two-member Board and an Executive Committee replace the divisional CEOs; management layers are being cut to remove bureaucracy and speed up decisions.
- **Cost-out programme**: The programme targets EUR 300 million a year of savings by 2027. It reached a EUR 41 million run rate in Q2 2026 and is on track for about EUR 150 million in 2026 and EUR 200-250 million in 2027.
- **One Group, no separation**: The planned separation of Specialties and Essentials was dropped: one Group, one brand, two divisions on a shared supply chain backbone.
- **Strategic review**: A strategic review aims to build the most competitive and scalable global distribution supply chain; its outcome and an updated strategy are due in H2 2026, with a Capital Markets Day set for 12 November 2026.
- **Data, ERP and decarbonisation**: The Digital.Data.Excellence (DiDEX) programme harmonises master data and the ERP landscape; SBTi-validated targets aim for net zero by 2050 and a 58.8% cut in Scope 1 and 2 emissions by 2034 versus 2023.

## Latest results

In H1 2026 sales were EUR 7,925m, roughly flat (+3.0% fx-adjusted), as a meaningful rise in sales prices offset slightly lower volumes. Operating gross profit rose to EUR 2,096m (+8.8% fx-adjusted) and operating EBITDA to EUR 770m (+16.1% fx-adjusted), with a strong Q2 (operating EBITDA EUR 463m, +40.9% fx-adjusted) as the Iran conflict and the Strait of Hormuz closure pushed up chemical prices. Free cash flow fell to EUR 97m on a EUR 460m working capital build, and net financial liabilities rose to EUR 3,100m. 2026 operating EBITDA guidance was raised twice, to EUR 1,350-1,450m from EUR 1,150-1,350m at the start of the year.

## Investments and deals

- **Chem Tech Services acquisition**: Bought in November 2025: an oilfield chemical solutions provider in Texas and New Mexico with 2024 sales of USD 79 million.
- **Airedale Group acquisition**: Closed at the end of February 2026 (Keighley, UK; 2025 sales GBP 77 million), adding blending, formulation and dilution capabilities in the UK. Transactions signed or closed in 2025 totalled EUR 260 million.
- **Site network capex**: FY2025 capex was EUR 293.0m, mostly on sites, for example a EUR 10.6m truck fleet upgrade in France and EUR 7.1m at two Polish sites; EUR 23.0m of intangible investment went mainly to digitalisation.
- **Portfolio pruning**: Raj Petro Specialties (India) and its Dubai subsidiary were sold to focus the divisions on their core.

## Challenges and risks

- **Prolonged chemical downturn**: Management calls 2025 part of the longest downturn in the chemical industry in more than 20 years, with global overcapacity and pricing pressure; FY2025 operating EBITA fell 12.6% fx-adjusted and missed every guidance range.
- **Chinese competition**: Chinese overcapacity is flooding Europe and Latin America, and Chinese producers are back in APAC pushing volumes aggressively.
- **Price volatility and working capital**: Higher prices lifted H1 2026 margins but tied up working capital; an end to the Hormuz crisis would likely compress gross profit, and guidance assumes the price benefit fades through Q3.
- **Impairments and legal risk**: FY2025 profit after tax fell to EUR 269.7m after goodwill impairments in Latin America and APAC; talc litigation in North America led to EUR 32.2m of legal-risk expenses in 2025.
- **Protectionism and geopolitics**: US protectionism, geopolitical conflicts and customers relocating to low-cost countries are named risks to demand.

## What leadership says

> "I haven't said growth, I said sales. We can't control the market turnaround, but we can control how much effort we make on sale." — Jens Birgersson, CEO, Brenntag 9M 2025 Results Call, 12 November 2025

> "We don't run a matrix. I don't want to run a matrix." — Jens Birgersson, CEO, Brenntag 9M 2025 Results Call, 12 November 2025

> "I see us as a benefactor of the Chinese on the specialty." — Jens Birgersson, CEO, Brenntag Q2 2026 Results Call, 12 August 2026

> "using this phase of market softness to strengthen our structural foundations" — Jens Birgersson, CEO, CEO letter, Brenntag Annual Report 2025, March 2026


## Where a supplier can help

- **Sales productivity and pricing tools**: Tied to the sales and market-share priority: tools for cross-selling between divisions, reactivating dormant customers and AI-supported pricing fit the push to grow through share rather than market volume.
- **Overhead and process efficiency**: Tied to the cost-out programme: automation and shared-service offers that cut administrative cost at headquarters and support functions serve the EUR 300 million annual savings target.
- **Master data and ERP harmonisation**: Tied to the DiDEX data and technology transformation: suppliers of data management, ERP integration and digital sales channels can support the shared backbone of two divisions.
- **Logistics and site network**: Tied to site-network capex and possible site consolidations: fleet, warehouse and cross-docking solutions match investments such as the truck fleet upgrade in France and the Polish site consolidation.
- **Post-acquisition integration**: Tied to bolt-on M&A such as Chem Tech and Airedale: integration services for systems and operations help absorb acquired businesses into the Group.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Brenntag Annual Report 2025](https://brenntagprod-media.e-spirit.cloud/06432017-be1f-41ce-8d1d-564e2a66d213/documents/corporate/investor-relations/2025/annual-report-2025/brenntag_annual-report-2025_en.pdf)

Annual report · 2026-03-12

- Brenntag is the global market leader in chemical and ingredients distribution: around 600 sites in more than 70 countries, 17,339 employees, sales of EUR 15,171.5m in 2025.
- FY 2025: sales -3.7% fx-adjusted; operating gross profit EUR 3,831.7m (-1.9%); operating EBITDA EUR 1,287.5m; operating EBITA EUR 929.3m (-12.6%), below every guidance range; profit after tax EUR 269.7m after goodwill impairments in Latin America and APAC; free cash flow EUR 940.8m; dividend EUR 1.90 (about -10%).
- Two divisions: Brenntag Essentials (process chemicals; EUR 10,370.3m external sales; EMEA, North America, Latin America, APAC, Transregional) and Brenntag Specialties (ingredients; EUR 4,801.2m; Life Science = Nutrition, Pharma, Beauty & Care; Material Science = CASE, Construction, Polymers, Rubber).
- North America is the largest segment (EUR 4,694.1m external sales); the U.S. alone accounts for EUR 5,165.4m of sales by entity country.
- New CEO Jens Birgersson (ex-Rockwool) since 1 September 2025 and CFO Thomas Reisten; since 1 December 2025 a two-member Board plus an Executive Committee replaces the divisional CEOs.
- The planned separation of Specialties and Essentials is dropped: one Group, one brand, two divisions on a shared backbone.
- Cost-out program targets EUR 300 million a year of savings; EUR 115 million of further gross run-rate savings were delivered in 2025, and headcount fell organically by 1,007.
- Priorities: sales, clarity and simplification, execution; a strategic review and updated strategy are due in H2 2026; acquisitions of Chem Tech (U.S.) and Airedale (UK).
- 2026 guidance: operating EBITDA EUR 1,150-1,350m in a market expected to decline about 2.5%.

### [Brenntag Half-Year Financial Report January - June 2026](https://brenntagprod-media.e-spirit.cloud/06432017-be1f-41ce-8d1d-564e2a66d213/documents/corporate/investor-relations/2026/q2-2026/brenntag-se_h1_2026_financial-report.pdf)

Interim report · 2026-08-12

- H1 2026 sales EUR 7,925m (roughly flat, +3.0% fx-adjusted) on a meaningful rise in sales prices; volumes slightly lower.
- Operating gross profit EUR 2,096m (+8.8% fx-adjusted); operating EBITDA EUR 770m (+16.1% fx-adjusted); EPS EUR 1.92 vs EUR 1.23.
- A strong Q2: operating EBITDA EUR 463m (+40.9% fx-adjusted), as the Iran conflict and the Strait of Hormuz closure pushed up chemical prices and volatility.
- Essentials led: operating EBITDA EUR 574m (+18.1% fx-adjusted); Specialties EUR 250m (+10.2%), with Material Science gross profit +11.9% while Life Science fell 3.4%.
- Free cash flow fell to EUR 97m (-69.3%) on a EUR 460m working capital build; net financial liabilities EUR 3,100m.
- Airedale Group (UK, 2025 sales GBP 77m) acquired at the end of February 2026; headcount 16,942.
- 2026 operating EBITDA guidance raised twice, now EUR 1,350-1,450m (from EUR 1,150-1,350m at the start of the year).

### [Brenntag Q2 2026 Results Call (transcript)](https://www.roic.ai/quote/BNTGF/transcripts/2026-year/2-quarter)

Executive talk · Jens Birgersson, CEO · 2026-08-12

- Q&A-only call with CEO Jens Birgersson and CFO Thomas Reisten; Capital Markets Day set for 12 November 2026.
- Volumes "holding steady", with no uptick expected; customers' April restocking is seen as normalized rather than an "inventory bubble".
- The base case assumes the wars continue and oil stays at 80-90. Higher price levels help Brenntag's gross profit; an end to the Hormuz crisis would compress it.
- Growth must come from market share: cross-selling between divisions, pharma domain experts paired with Essentials salespeople, 1,000 dormant U.S. customers won back, and AI used for pricing.
- Cost program at a EUR 41m run rate in Q2, on track for about EUR 150m in 2026 and EUR 200-250m in 2027; Birgersson says it is "not a hard stop".
- The EUR 353m Q2 working capital outflow is called a "temporary technical effect" of prices; guidance assumes the price benefit fades through Q3.
- Chinese producers are back in APAC and expected in Latin America; Birgersson sees Chinese supply as a benefit in Specialties.

### [Brenntag 9M 2025 Results Call (transcript)](https://www.roic.ai/quote/BNTGF/transcripts/2025-year/3-quarter)

Executive talk · Jens Birgersson, CEO · 2025-11-12

- This was Jens Birgersson's first call as CEO, after two months meeting 100-200 customers; he calls the commercial teams' culture the company's biggest strength.
- Three immediate priorities: sales ("I haven't said growth, I said sales"), clarity and simplification (no matrix, one layer removed, a new Executive Committee, a two-person Board), and execution of cost-out.
- He stopped the separation of Specialties and Essentials, citing synergies, the cost of splitting, and M&A targets that "have a little bit of both".
- A strategic review is under way, due in H2 2026, aiming at "the most competitive and scalable global distribution supply chain"; China and India Essentials strategies are still to be decided.
- Chinese overcapacity is hitting Europe and Latin America; outsourcing by the largest suppliers is moving more volume to Brenntag.
- CFO: Q3 operating EBITA EUR 243m (-9.2%), free cash flow EUR 316m, EUR 45m savings in the quarter; 2025 guidance put towards the lower end of EUR 950 million-1.050 billion.

## Questions about Brenntag

### What does Brenntag do?

Brenntag distributes chemicals and ingredients, buying around 20,000 products in bulk from producers and repacking, mixing and delivering them to customers. It also provides technical, regulatory and digital services through two divisions, Essentials and Specialties.

### What is Brenntag's revenue?

Sales were EUR 15,171.5m in FY2025, with operating EBITDA of EUR 1,287.5m. In H1 2026 sales were EUR 7,925m and operating EBITDA EUR 770m.

### How many employees does Brenntag have?

Brenntag had 17,339 employees at year-end 2025 and 16,942 at 30 June 2026, working from around 600 sites in more than 70 countries.

### Who leads Brenntag?

Jens Birgersson, previously CEO of the Rockwool Group, has been CEO since 1 September 2025; Thomas Reisten has been CFO since 1 April 2025.

### What is Brenntag's strategy?

Brenntag keeps both divisions in one Group and focuses on sales, simplification and a cost-out programme targeting EUR 300 million a year of savings. A strategic review and updated strategy are due in H2 2026.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
